Last reviewed · How we verify
ENJUVIA (ESTROGENS, CONJUGATED SYNTHETIC B)
ENJUVIA (generic name: ESTROGENS, CONJUGATED SYNTHETIC B) is a drug developed by DURAMED. It is currently FDA-approved.
At a glance
| Generic name | ESTROGENS, CONJUGATED SYNTHETIC B |
|---|---|
| Sponsor | DURAMED |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
- Headache
- Pain
- Abdominal Pain
- Accidental Injury
- Flu Syndrome
- Flatulence
- Nausea
- Vomiting
- Breast Tenderness
- Breast Enlargement
- Vaginal Bleeding Changes
- Breakthrough Bleeding
Serious adverse events
- Breast Cancer
- Endometrial Cancer
- Ovarian Cancer
- Pulmonary Embolism
- Deep Venous Thrombosis
- Myocardial Infarction
- Stroke
- Thrombophlebitis
- Gallbladder Disease
- Pancreatitis
Key clinical trials
- A Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of SCE-B on Nocturnal Vasomotor Symptoms in Postmenopausal Women (Phase 4)
- A Randomized, Multicenter, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Synthetic Conjugated Estrogens, B (Enjuvia) 0.3 mg Tablets for the Treatment of Vulvovaginal At (Phase 3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ENJUVIA CI brief — competitive landscape report
- ENJUVIA updates RSS · CI watch RSS
- DURAMED portfolio CI
Frequently asked questions about ENJUVIA
What is ENJUVIA?
ENJUVIA (ESTROGENS, CONJUGATED SYNTHETIC B) is a pharmaceutical drug developed by DURAMED.
Who makes ENJUVIA?
ENJUVIA is developed and marketed by DURAMED (see full DURAMED pipeline at /company/duramed).
What is the generic name of ENJUVIA?
ESTROGENS, CONJUGATED SYNTHETIC B is the generic (nonproprietary) name of ENJUVIA.
What development phase is ENJUVIA in?
ENJUVIA is FDA-approved (marketed).
What are the side effects of ENJUVIA?
Common side effects of ENJUVIA include Headache, Pain, Abdominal Pain, Accidental Injury, Flu Syndrome, Flatulence. Serious adverse events: Breast Cancer, Endometrial Cancer, Ovarian Cancer, Pulmonary Embolism.
Related
- Manufacturer: DURAMED — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing